Fuad El-Hibri Chairman of the Board of Directors and Chief Executive Officer Emergent BioSolutions Inc.
Professional Background Mr. Fuad El-Hibri is the Chairman and Chief Executive Officer of Emergent BioSolutions Inc. (Emergent), a publicly traded biopharmaceutical company focused on developing, manufacturing and commercializing vaccines and therapeutics to prevent and treat life-threatening diseases. The company’s current marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only FDA-licensed vaccine for pre-exposure prophylaxis of anthrax disease. The company is also investing heavily in the development of a broad pipeline of products that address specific global unmet medical needs, including Typhoid, Tuberculosis, Hepatitis B and Chlamydia.
Mr. El-Hibri has extensive experience in the biopharmaceutical industry beginning with Porton Products, Ltd. (Porton), a mid-sized biotechnology company in the United Kingdom. Subsequent to the successful marketing and …
- Last name
- Fuad El-Hibri
- Date of birth
- 19/04/1953
- Location
- (Baden-Wurttemberg)
Germany - Native language
- English
- Company
- BioSolutions Inc.
- Profession
- Business & Administration (Manager)
- Tags
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=f334a4f1-233a-4012-9ccc-11caee122aaa)
